International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort studyWolfgang R. Sperr, Peter Valent, Massimiliano Bonifacio et al.|The Lancet Haematology|2019Cited by 140
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classificationJakub Trizuljak, Wolfgang R. Sperr, Lucie Nekvindová et al.|Allergy|2020Cited by 77
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and PerspectivesPeter Valent, Wolfgang R. Sperr, J. N. G. Oude Elberink et al.|The Journal of Allergy and Clinical Immunology In Practice|2018Cited by 57
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM RegistryHanneke C. Kluin‐Nelemans, Wolfgang R. Sperr, Andreas Reiter et al.|Leukemia|2019Cited by 55
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosisHanneke C. Kluin‐Nelemans, Wolfgang R. Sperr, Mohamad Jawhar et al.|Theranostics|2020Cited by 43